bf/NASDAQ:VRTX_icon.jpeg

NASDAQ:VRTX

Vertex Pharmaceuticals Incorporated

  • Stock

USD

Last Close

401.08

06/05 18:49

Market Cap

110.85B

Beta: 0.49

Volume Today

755.20K

Avg: 1.12M

PE Ratio

31.95

PFCF: 26.33

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
22.31M
-
22.50M
0.86%
43.47M
93.20%
66.84M
53.79%
94.72M
41.70%
118.09M
24.68%
145.93M
23.57%
224.14M
53.59%
316.94M
41.40%
406.85M
28.37%
599.70M
47.40%
average payables
75.31M
-
60.26M
19.98%
73.07M
21.25%
68.20M
6.67%
67.72M
0.70%
92.49M
36.57%
99.30M
7.36%
121.37M
22.23%
175.07M
44.24%
249.45M
42.49%
334.40M
34.05%
average receivables
114.38M
-
79.26M
30.71%
125.32M
58.12%
189.36M
51.11%
241.21M
27.38%
345.52M
43.24%
521.60M
50.96%
759.43M
45.60%
1.01B
33.14%
1.29B
27.54%
1.50B
16.54%
book value per share
6.03
-
4.66
22.76%
4.53
2.80%
5.47
20.78%
8.21
50.06%
17.44
112.53%
23.70
35.90%
33.43
41.04%
39.19
17.23%
54.33
38.61%
67.49
24.23%
capex per share
-0.23
-
-0.22
4.78%
-0.19
13.72%
-0.23
23.14%
-1.04
350.95%
-0.38
63.96%
-0.29
21.76%
-1.00
240.20%
-0.91
8.79%
-0.80
12.35%
-0.99
24.10%
capex to depreciation
-1.06
-
-0.81
23.83%
-0.73
10.22%
-0.92
26.78%
-4.23
358.65%
-1.32
68.78%
-0.71
46.51%
-2.37
236.23%
-1.87
21.13%
-1.38
26.23%
-1.43
3.26%
capex to operating cash flow
1.00
-
0.10
89.99%
0.12
24.26%
-0.24
293.25%
-0.31
28.16%
-0.08
75.51%
-0.05
36.06%
-0.08
66.09%
-0.09
11.33%
-0.05
44.24%
-0.07
47.38%
capex to revenue
-0.04
-
-0.09
108.03%
-0.04
50.25%
-0.03
24.28%
-0.10
213.70%
-0.03
69.93%
-0.02
42.17%
-0.04
130.98%
-0.03
25.89%
-0.02
26.12%
-0.03
14.58%
cash per share
6.51
-
5.89
9.51%
4.32
26.72%
5.86
35.72%
8.39
43.16%
12.46
48.45%
14.83
19.06%
25.63
72.76%
29.20
13.94%
42.09
44.13%
43.08
2.35%
days of inventory on hand
39.64
-
184.62
365.79%
163.06
11.68%
134.59
17.46%
148.36
10.24%
110.84
25.30%
111.62
0.70%
139.19
24.70%
142.54
2.41%
155.62
9.18%
213.64
37.28%
days payables outstanding
138.20
-
426.09
208.31%
217.89
48.86%
106.57
51.09%
98.17
7.89%
98.92
0.76%
58.38
40.98%
76.91
31.74%
78.72
2.35%
102.68
30.44%
105.52
2.77%
days sales outstanding
25.75
-
45.90
78.23%
62.81
36.83%
43.12
31.35%
41.26
4.30%
49.07
18.91%
55.55
13.21%
52.07
6.25%
54.78
5.20%
58.94
7.60%
58.00
1.60%
debt to assets
0.20
-
0.37
85.87%
0.36
0.94%
0.40
10.06%
0.17
58.66%
0.09
44.14%
0.07
20.92%
0.05
27.32%
0.04
15.36%
0.03
31.22%
0.04
15.07%
debt to equity
0.34
-
0.78
131.71%
0.83
6.21%
0.87
4.15%
0.29
66.81%
0.13
54.70%
0.10
23.24%
0.07
28.08%
0.06
16.79%
0.04
32.53%
0.05
14.04%
dividend yield
0.00
-
0.00
63.86%
0.00
2,314.00%
0.00
58.22%
earnings yield
-0.03
-
-0.03
0.79%
-0.02
30.43%
-0.01
66.18%
0.01
213.66%
0.05
604.33%
0.02
57.93%
0.04
110.91%
0.04
6.27%
0.04
8.53%
0.03
23.98%
enterprise value
16.58B
-
28.15B
69.79%
30.47B
8.22%
17.68B
41.98%
36.19B
104.71%
40.06B
10.67%
53.68B
34.01%
56.00B
4.33%
50.35B
10.09%
64.01B
27.13%
96.43B
50.64%
enterprise value over ebitda
32.86
-
-46.07
240.20%
-64.40
39.77%
1.15K
1,891.20%
116.21
89.93%
60.40
48.02%
36.82
39.04%
17.57
52.29%
18.06
2.78%
14.73
18.41%
24.53
66.49%
ev to operating cash flow
-321.55
-
-54.86
82.94%
-83.38
51.99%
74.88
189.81%
42.83
42.80%
31.53
26.38%
34.20
8.47%
17.21
49.68%
19.05
10.66%
15.50
18.63%
27.26
75.88%
ev to sales
13.68
-
48.51
254.54%
29.52
39.15%
10.39
64.81%
14.54
40.01%
13.14
9.62%
12.89
1.89%
9.02
30.01%
6.65
26.34%
7.17
7.82%
9.80
36.73%
free cash flow per share
-0.46
-
-2.40
423.93%
-1.70
29.04%
0.73
143.11%
2.35
220.65%
4.62
96.35%
5.82
25.96%
11.52
98.00%
9.35
18.88%
15.33
63.99%
12.59
17.88%
free cash flow yield
-0.01
-
-0.02
227.68%
-0.01
33.00%
0.01
173.63%
0.02
57.63%
0.03
77.57%
0.03
4.67%
0.05
83.43%
0.04
12.70%
0.05
24.71%
0.03
41.71%
graham net net
2.55
-
0.92
63.82%
-0.83
190.09%
0.28
133.71%
3.42
1,121.39%
6.79
98.40%
8.31
22.39%
16.93
103.64%
20.26
19.70%
30.66
51.32%
29.23
4.68%
graham number
16.39
-
18.14
10.69%
15.35
15.37%
7.51
51.10%
13.98
86.26%
56.89
306.84%
49.44
13.08%
88.60
79.19%
89.52
1.04%
125.92
40.65%
145.25
15.36%
income quality
0.08
-
0.69
821.20%
0.62
10.08%
-2.81
552.24%
9.22
428.17%
0.61
93.40%
1.33
119.10%
1.20
10.03%
1.13
5.93%
1.24
10.15%
0.98
21.39%
intangibles to total assets
0.01
-
0.03
120.72%
0.13
354.44%
0.12
13.71%
0.02
80.65%
0.01
63.97%
0.17
1,989.57%
0.12
29.22%
0.10
12.51%
0.09
10.72%
0.08
8.99%
interest coverage
-39.75
-
-9.50
76.09%
-5.57
41.43%
0.12
102.19%
2.14
1,655.09%
18.62
769.29%
20.47
9.96%
49.12
139.95%
45.24
7.90%
78.60
73.75%
85.04
8.19%
interest debt per share
2.14
-
3.95
85.00%
4.11
3.98%
5.06
23.21%
2.59
48.90%
2.40
7.14%
2.59
7.98%
2.62
1.16%
2.58
1.68%
2.40
6.83%
3.27
36.10%
inventory turnover
9.21
-
1.98
78.53%
2.24
13.23%
2.71
21.15%
2.46
9.29%
3.29
33.86%
3.27
0.70%
2.62
19.81%
2.56
2.35%
2.35
8.41%
1.71
27.16%
invested capital
0.34
-
0.78
131.71%
0.83
6.21%
0.87
4.15%
0.29
66.81%
0.13
54.70%
0.10
23.24%
0.07
28.08%
0.06
16.79%
0.04
32.53%
0.05
14.04%
market cap
16.71B
-
27.95B
67.29%
30.36B
8.62%
18.03B
40.63%
37.29B
106.89%
42.14B
12.99%
56.21B
33.39%
61.41B
9.25%
56.59B
7.85%
73.96B
30.69%
105.99B
43.32%
net current asset value
625.94M
-
308.01M
50.79%
-49.27M
116.00%
205.41M
516.90%
979.62M
376.90%
1.89B
93.09%
2.38B
25.61%
4.76B
100.33%
5.68B
19.38%
8.44B
48.59%
8.99B
6.53%
net debt to ebitda
-0.25
-
-0.33
28.68%
-0.22
31.66%
-22.55
9,982.09%
-3.54
84.32%
-3.14
11.19%
-1.74
44.71%
-1.70
2.35%
-2.24
31.90%
-2.29
2.30%
-2.43
6.31%
net income per share
-1.98
-
-3.14
58.62%
-2.31
26.31%
-0.46
80.20%
1.06
331.20%
8.25
678.83%
4.58
44.41%
10.44
127.66%
9.09
12.91%
12.97
42.72%
13.89
7.12%
operating cash flow per share
-0.23
-
-2.18
851.16%
-1.51
30.57%
0.96
163.72%
3.40
251.87%
5.00
47.13%
6.11
22.37%
12.52
104.83%
10.26
18.07%
16.13
57.20%
13.58
15.80%
payables turnover
2.64
-
0.86
67.57%
1.68
95.56%
3.42
104.45%
3.72
8.56%
3.69
0.76%
6.25
69.44%
4.75
24.09%
4.64
2.30%
3.55
23.34%
3.46
2.69%
receivables turnover
14.17
-
7.95
43.89%
5.81
26.91%
8.47
45.66%
8.85
4.50%
7.44
15.90%
6.57
11.67%
7.01
6.67%
6.66
4.94%
6.19
7.06%
6.29
1.63%
research and ddevelopement to revenue
0.76
-
1.47
94.43%
0.96
34.53%
0.62
36.22%
0.53
13.52%
0.46
12.68%
0.42
9.32%
0.29
30.05%
0.40
36.63%
0.28
29.39%
0.38
31.85%
return on tangible assets
-0.19
-
-0.33
67.47%
-0.26
20.76%
-0.04
83.04%
0.08
273.58%
0.34
345.30%
0.17
49.73%
0.26
53.98%
0.19
25.69%
0.20
3.67%
0.17
13.79%
revenue per share
5.39
-
2.47
54.23%
4.28
73.44%
6.96
62.61%
10.00
43.75%
11.98
19.84%
16.21
35.30%
23.88
47.29%
29.39
23.07%
34.87
18.64%
37.77
8.31%
roe
-0.33
-
-0.67
105.35%
-0.51
24.19%
-0.08
83.61%
0.13
254.07%
0.47
266.46%
0.19
59.10%
0.31
61.42%
0.23
25.71%
0.24
2.97%
0.21
13.77%
roic
-0.28
-
-0.28
0.28%
-0.20
30.47%
0.00
102.09%
-0.23
5,624.93%
0.40
275.56%
0.14
64.89%
0.25
80.77%
0.21
15.63%
0.23
6.74%
0.16
28.32%
sales general and administrative to revenue
shareholders equity per share
6.03
-
4.66
22.76%
4.53
2.80%
5.47
20.78%
8.21
50.06%
17.44
112.53%
23.70
35.90%
33.43
41.04%
39.19
17.23%
54.33
38.61%
67.49
24.23%
stock based compensation to revenue
0.11
-
0.31
191.22%
0.22
26.84%
0.14
37.60%
0.12
16.34%
0.11
8.70%
0.09
18.81%
0.07
20.08%
0.06
15.79%
0.06
5.60%
0.06
7.38%
tangible asset value
1.33B
-
1.03B
22.49%
757.96M
26.22%
1.00B
32.39%
1.96B
95.61%
4.38B
123.38%
4.68B
6.80%
7.28B
55.55%
8.70B
19.40%
12.22B
40.51%
15.65B
28.08%
tangible book value per share
5.42
-
4.37
19.49%
3.14
28.05%
4.10
30.57%
7.89
92.33%
17.24
118.61%
16.68
3.25%
26.50
58.81%
32.20
21.53%
47.72
48.20%
60.09
25.91%
working capital
1.19B
-
1.18B
0.91%
848.75M
28.07%
1.75B
106.55%
1.68B
4.39%
2.99B
78.20%
3.40B
13.99%
6.26B
84.00%
7.14B
13.99%
10.25B
43.54%
10.60B
3.38%

All numbers in USD (except ratios and percentages)